Lunai Bioworks Inc. (RENB)
NASDAQ: RENB
· Real-Time Price · USD
1.42
0.00 (0.00%)
At close: Jun 09, 2025, 3:59 PM
Lunai Bioworks Income Statement
Financials in USD. Fiscal
year is
July - June.
| Fiscal Year | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 |
Revenue | n/a | n/a | n/a | 181.45K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 31.98K | 32.11K | 32.38K | 90.73K | 30.3K | 33.16K | 27.26K | 28.01K | 28.24K | 28.84K | n/a | 28.33K | 101.8K | 101.16K | 100.39K |
Gross Profit | -31.98K | -32.11K | -32.38K | 90.73K | -30.3K | -33.16K | -27.26K | -28.01K | -28.24K | -28.84K | n/a | -28.33K | -101.8K | -101.16K | -100.39K |
Operating Income | -4.16M | -4.55M | -53.34M | -17.1M | -17.19M | -4.27M | -8.88M | -22.93M | -4.06M | -4.37M | -7.19M | -4.96M | -4.03M | -6.33M | -7.5M |
Interest Income | n/a | n/a | 126.6K | n/a | n/a | 15.94K | 8.38K | n/a | n/a | 3.01K | 5.62K | 99.15K | 7.29K | 8.49K | 7.11K |
Pretax Income | 189.18K | -7.25M | -44.21M | -15.73M | -17.02M | -4.53M | -9.18M | -23.2M | -4.33M | -4.46M | -7.7M | -90.24M | -6.2M | -6.58M | -10.41M |
Net Income | 189.18K | -7.25M | -44.21M | -15.73M | -17.02M | -4.53M | -9.18M | -23.2M | -4.33M | -4.46M | -7.7M | -90.24M | -6.2M | -6.58M | -10.41M |
Selling & General & Admin | 4.22M | 4.35M | 5.3M | 5M | 7.65M | 3.62M | 8.29M | 2.95M | 3.8M | 4.01M | 4.56M | 3.16M | 2.72M | 4.09M | 4.4M |
Research & Development | 94.07K | 161.08K | 390.19K | 434.51K | 1.09M | 620.52K | 566.64K | 994.73K | 239.14K | 325.96K | 2.61M | 1.77M | 1.21M | 2.14M | 3.01M |
Other Expenses | -156.17K | 32.11K | 47.65M | 45.86M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 4.16M | 4.55M | 53.34M | 51.29M | 8.77M | 4.27M | 8.88M | 3.97M | 4.06M | 4.34M | 7.61M | 4.93M | 3.93M | 6.23M | 7.4M |
Interest Expense | 188.61K | 116.08K | 250.08K | 261.31K | 320.07K | 274.98K | 179.27K | 262.26K | 264.86K | 92.89K | 95.58K | 94.52K | 95.21K | 93.38K | 89.74K |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 43.42K | 43.93K | n/a | n/a | n/a | n/a |
Cost & Expenses | 4.16M | 4.55M | 53.34M | 51.29M | 8.77M | 4.27M | 8.88M | 3.97M | 4.06M | 4.37M | 7.61M | 4.96M | 4.03M | 6.33M | 7.5M |
Income Tax Expense | n/a | n/a | n/a | n/a | 320.07K | 15.94K | n/a | n/a | n/a | -4 | n/a | -2 | 5.00 | n/a | 34.00 |
Shares Outstanding (Basic) | 16.23M | 16.18M | 15.66M | 9.62M | 10.75M | 6.59M | 6.45M | 6.37M | 5.6M | 5.55M | 5.51M | 5.3M | 5.26M | 5.23M | 5.22M |
Shares Outstanding (Diluted) | 16.39M | 16.18M | 15.66M | 9.62M | 10.75M | 6.59M | 6.45M | 6.37M | 5.6M | 5.55M | 5.51M | 5.3M | 5.26M | 5.23M | 5.22M |
EPS (Basic) | 0.01 | -0.45 | -2.8 | -1.6 | -1.6 | -0.69 | -1.4 | -3.6 | -0.77 | -0.8 | -1.4 | -17 | -1.2 | -1.3 | -2 |
EPS (Diluted) | 0.01 | -0.45 | -2.8 | -1.6 | -1.6 | -0.69 | -1.4 | -3.6 | -0.77 | -0.8 | -1.4 | -17 | -1.2 | -1.3 | -2 |
EBITDA | 409.84K | -7.12M | -43.93M | -52.19M | -50.88M | -4.22M | -8.97M | -22.9M | -4.04M | -4.34M | -7.58M | -90.11M | -6M | -6.39M | -10.22M |
EBIT | 377.86K | -7.14M | -43.96M | -48.24M | -50.89M | -4.25M | -9M | -22.94M | -4.06M | -4.36M | -7.6M | -90.14M | -6.11M | -6.49M | -10.32M |
Depreciation & Amortization | 31.98K | 32.11K | 32.38K | 31.13K | 30.3K | 33.16K | 27.26K | 28.01K | 28.24K | 28.84K | 28.4K | 28.33K | 101.8K | 101.16K | 100.39K |